BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 825707)

  • 21. [Course controls of hepatitis B antigen during and after acute virus hepatitis in the years 1964 to 1972].
    Alexander M; Scholz V; Wenzel H
    Verh Dtsch Ges Inn Med; 1973; 79():977-9. PubMed ID: 4790061
    [No Abstract]   [Full Text] [Related]  

  • 22. Viral hepatitis.
    Herlong HF; Maddrey WC
    Prim Care; 1979 Sep; 6(3):505-15. PubMed ID: 118474
    [No Abstract]   [Full Text] [Related]  

  • 23. Acute virus hepatitis: immunology.
    Zuckerman AJ
    Trans Med Soc Lond; 1973; 89():58-70. PubMed ID: 4376631
    [No Abstract]   [Full Text] [Related]  

  • 24. Clinical pathologic correlation in viral hepatitis. The effect of the virus on the liver.
    Popper H
    Am J Pathol; 1975 Dec; 81(3):609-28. PubMed ID: 1108667
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Infectivity of hepatitis B].
    Gerken G
    Dtsch Med Wochenschr; 1996 Apr; 121(14):459. PubMed ID: 8665822
    [No Abstract]   [Full Text] [Related]  

  • 26. Statement on immunizing agents for the prevention of hepatitis.
    CMAJ; 1987 Aug; 137(4):303-7. PubMed ID: 2440548
    [No Abstract]   [Full Text] [Related]  

  • 27. Recommendations for protection against viral hepatitis.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1985 Jun; 34(22):313-24, 329-35. PubMed ID: 3923311
    [No Abstract]   [Full Text] [Related]  

  • 28. Viral hepatitis.
    Purcell RH
    Prev Med; 1974 Dec; 3(4):529-34. PubMed ID: 4438284
    [No Abstract]   [Full Text] [Related]  

  • 29. [Australia antigen and hepatitis].
    Müller J; Grob PJ
    Helv Med Acta Suppl; 1970 Jun; ():Suppl 50:107. PubMed ID: 5288594
    [No Abstract]   [Full Text] [Related]  

  • 30. Prophylaxis of viral hepatitis.
    Kaboth U; Junge U
    Clin Gastroenterol; 1974 May; 3(2):453-70. PubMed ID: 4138500
    [No Abstract]   [Full Text] [Related]  

  • 31. [Behavior of the serum concentration of the C3 component of complement during viral hepatitis].
    Bazzicalupo G; Pietranera P; Bellodi G
    Boll Ist Sieroter Milan; 1971; 50(2):95-8. PubMed ID: 5004395
    [No Abstract]   [Full Text] [Related]  

  • 32. [Significance of hepatitis B antigens].
    Baumgarten R; Fengler JD
    Z Arztl Fortbild (Jena); 1977 Feb; 71(4):172-5. PubMed ID: 868091
    [No Abstract]   [Full Text] [Related]  

  • 33. Aspects of the ecology of viral hepatitis.
    Zuckerman AJ
    Ecol Dis; 1983; 2(2):135-44. PubMed ID: 6432521
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Infectious particles in hepatitis.
    Waterson AP
    Annu Rev Med; 1976; 27():23-35. PubMed ID: 180873
    [No Abstract]   [Full Text] [Related]  

  • 35. [Australia antigen in acute and chronic hepatitis].
    Grob PJ; Jemelka HJ; Müller JW
    Schweiz Rundsch Med Prax; 1971 Feb; 60(8):230-7. PubMed ID: 4995012
    [No Abstract]   [Full Text] [Related]  

  • 36. Progress in hepatitis research.
    Silver S
    Am J Med Technol; 1975 Apr; 41(4):154-6. PubMed ID: 165721
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Score: hepatitis viruses 5, vaccines 1. Researchers believe sixth virus exists.
    Russell B
    Am Nurse; 1992 Sep; 24(8):1, 11. PubMed ID: 1387770
    [No Abstract]   [Full Text] [Related]  

  • 38. Acute virus hepatitis.
    Sherlock S
    Trans Med Soc Lond; 1973; 89():47-58. PubMed ID: 4376630
    [No Abstract]   [Full Text] [Related]  

  • 39. The evolving serology of viral hepatitis.
    Carey WD
    Prim Care; 1981 Jun; 8(2):251-63. PubMed ID: 6794059
    [No Abstract]   [Full Text] [Related]  

  • 40. [Epidemiology of A and B hepatitis].
    Larouze B; Buffet C
    Rev Prat; 1978 May; 35(25):1883-93. PubMed ID: 675106
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.